![jean marie BRUEY | Group Leader | Ph.D | Genentech, California | Department of Oncology | Research profile jean marie BRUEY | Group Leader | Ph.D | Genentech, California | Department of Oncology | Research profile](https://www.researchgate.net/profile/Maria-Ariza-4/publication/10987631/figure/fig5/AS:668409037586432@1536372541176/Differential-effects-of-ASC-on-NF-B-activation-A-and-B-HEK293T-cells-were-transfected_Q320.jpg)
jean marie BRUEY | Group Leader | Ph.D | Genentech, California | Department of Oncology | Research profile
PRELIMINARY CLINICAL AND BIOLOGIC RESULTS OF GB1275, A FIRST-IN-CLASS ORAL CD11B MODULATOR, ALONE AND WITH PEMBROLIZUMAB, IN AD
![HGF/MET-directed therapeutics in gastroesophageal cancer: a review of clinical and biomarker development. - Abstract - Europe PMC HGF/MET-directed therapeutics in gastroesophageal cancer: a review of clinical and biomarker development. - Abstract - Europe PMC](https://europepmc.org/articles/PMC4102777/bin/oncotarget-05-2866-g001.jpg)
HGF/MET-directed therapeutics in gastroesophageal cancer: a review of clinical and biomarker development. - Abstract - Europe PMC
![TORREY, a Phase 2 study to evaluate the efficacy and safety of inhaled seralutinib for the treatment of pulmonary arterial hypertension - Robert P. Frantz, Raymond L. Benza, Richard N. Channick, Kelly TORREY, a Phase 2 study to evaluate the efficacy and safety of inhaled seralutinib for the treatment of pulmonary arterial hypertension - Robert P. Frantz, Raymond L. Benza, Richard N. Channick, Kelly](https://journals.sagepub.com/cms/10.1177/20458940211057071/asset/images/large/10.1177_20458940211057071-fig1.jpeg)
TORREY, a Phase 2 study to evaluate the efficacy and safety of inhaled seralutinib for the treatment of pulmonary arterial hypertension - Robert P. Frantz, Raymond L. Benza, Richard N. Channick, Kelly
![Clinical Significance of Circulating Ki-67 Protein and Caspase-3 Activity Levels in Chronic Myeloid Leukemia. - ScienceDirect Clinical Significance of Circulating Ki-67 Protein and Caspase-3 Activity Levels in Chronic Myeloid Leukemia. - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0006497119570562-fx1.jpg)
Clinical Significance of Circulating Ki-67 Protein and Caspase-3 Activity Levels in Chronic Myeloid Leukemia. - ScienceDirect
![PAN1/NALP2/PYPAF2, an Inducible Inflammatory Mediator That Regulates NF-κB and Caspase-1 Activation in Macrophages* - Journal of Biological Chemistry PAN1/NALP2/PYPAF2, an Inducible Inflammatory Mediator That Regulates NF-κB and Caspase-1 Activation in Macrophages* - Journal of Biological Chemistry](https://www.jbc.org/cms/asset/28d7e1be-877f-4112-9bb5-84fd30bdef74/gr1.jpg)
PAN1/NALP2/PYPAF2, an Inducible Inflammatory Mediator That Regulates NF-κB and Caspase-1 Activation in Macrophages* - Journal of Biological Chemistry
![PDF) Mitochondria-targeting drugs arsenic trioxide and lonidamine bypass the resistance of TPA-differentiated leukemic cells to apoptosis | Laurent Corcos - Academia.edu PDF) Mitochondria-targeting drugs arsenic trioxide and lonidamine bypass the resistance of TPA-differentiated leukemic cells to apoptosis | Laurent Corcos - Academia.edu](https://0.academia-photos.com/attachment_thumbnails/95023116/mini_magick20221129-1-x6cmhw.png?1669730795)